title: Re: potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Kane
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor